|
US4083372A
(en)
|
1976-05-24 |
1978-04-11 |
Robert Boden |
Cigarette-simulating inhaler
|
|
US4393884A
(en)
|
1981-09-25 |
1983-07-19 |
Jacobs Allen W |
Demand inhaler for oral administration of tobacco, tobacco-like, or other substances
|
|
AU577259B2
(en)
*
|
1982-08-13 |
1988-09-22 |
Zymogenetics Inc. |
Glycolytic promters for regulated protein expression protease inhibitor
|
|
US4870008A
(en)
*
|
1983-08-12 |
1989-09-26 |
Chiron Corporation |
Secretory expression in eukaryotes
|
|
US4752576A
(en)
*
|
1984-06-14 |
1988-06-21 |
Chiron Corporation |
Expression of α-1 antitrypsin in yeast
|
|
US4732973A
(en)
*
|
1984-06-14 |
1988-03-22 |
Chiron Corporation |
Active site modified protease α-1-antitrypsin inhibitors
|
|
US4837148A
(en)
*
|
1984-10-30 |
1989-06-06 |
Phillips Petroleum Company |
Autonomous replication sequences for yeast strains of the genus pichia
|
|
US4735217A
(en)
|
1986-08-21 |
1988-04-05 |
The Procter & Gamble Company |
Dosing device to provide vaporized medicament to the lungs as a fine aerosol
|
|
US4765348A
(en)
|
1986-12-12 |
1988-08-23 |
Brown & Williamson Tobacco Corporation |
Non-combustible simulated cigarette device
|
|
US5217951A
(en)
*
|
1986-12-24 |
1993-06-08 |
John Lezdey |
Treatment of inflammation
|
|
US5114917A
(en)
*
|
1986-12-24 |
1992-05-19 |
John Lezdey |
Treatment of inflammation using alpha 1-antichymotrypsin
|
|
US5290762A
(en)
*
|
1986-12-24 |
1994-03-01 |
John Lezdey |
Treatment of inflammation
|
|
US5008242A
(en)
*
|
1986-12-24 |
1991-04-16 |
John Lezdey |
Treatment of inflammation using 1-antichymotrypsin
|
|
US5166134A
(en)
*
|
1986-12-24 |
1992-11-24 |
John Lezdey |
Treatment of allergic rhinitis
|
|
JP2656944B2
(ja)
*
|
1987-04-30 |
1997-09-24 |
クーパー ラボラトリーズ |
タンパク質性治療剤のエアロゾール化
|
|
US5159940A
(en)
|
1988-07-22 |
1992-11-03 |
Philip Morris Incorporated |
Smoking article
|
|
US4892109A
(en)
|
1989-03-08 |
1990-01-09 |
Brown & Williamson Tobacco Corporation |
Simulated smoking article
|
|
US6068994A
(en)
*
|
1989-08-07 |
2000-05-30 |
Chiron Corporation |
Ubiquitin expression system
|
|
US5113855A
(en)
|
1990-02-14 |
1992-05-19 |
Newhouse Michael T |
Powder inhaler
|
|
US5134119A
(en)
*
|
1990-10-16 |
1992-07-28 |
Lezdey John |
Treatment of inflammation using 358 substituted alpha-antitrypsin
|
|
US5892112A
(en)
|
1990-11-21 |
1999-04-06 |
Glycomed Incorporated |
Process for preparing synthetic matrix metalloprotease inhibitors
|
|
US5239078A
(en)
|
1990-11-21 |
1993-08-24 |
Glycomed Incorporated |
Matrix metalloprotease inhibitors
|
|
US5268384A
(en)
*
|
1990-11-21 |
1993-12-07 |
Galardy Richard E |
Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors
|
|
US5189178A
(en)
|
1990-11-21 |
1993-02-23 |
Galardy Richard E |
Matrix metalloprotease inhibitors
|
|
US5114953A
(en)
|
1990-11-21 |
1992-05-19 |
University Of Florida |
Treatment for tissue ulceration
|
|
US5256657A
(en)
*
|
1991-08-19 |
1993-10-26 |
Sterling Winthrop, Inc. |
Succinamide derivative matrix-metalloprotease inhibitors
|
|
US5287850A
(en)
|
1991-08-20 |
1994-02-22 |
Habley Medical Technology Corporation |
Timing and velocity controlled powered pharmaceutical inhaler
|
|
GB9215665D0
(en)
|
1992-07-23 |
1992-09-09 |
British Bio Technology |
Compounds
|
|
FR2696080B1
(fr)
|
1992-09-30 |
1994-12-23 |
Jesus Covarrubias |
Filtre à cigarette pour l'administration de taurine par inhalation.
|
|
US5441060A
(en)
|
1993-02-08 |
1995-08-15 |
Duke University |
Dry powder delivery system
|
|
GB2290543B
(en)
|
1993-03-16 |
1996-05-22 |
British Biotech Pharm |
Hydroxamic acid derivatives as metalloproteinase inhibitors
|
|
CA2160139A1
(en)
|
1993-04-07 |
1994-10-13 |
Richard Edward Galardy |
Synthetic matrix metalloprotease inhibitors and uses thereof
|
|
US5594106A
(en)
*
|
1993-08-23 |
1997-01-14 |
Immunex Corporation |
Inhibitors of TNF-α secretion
|
|
US6562596B1
(en)
|
1993-10-06 |
2003-05-13 |
Amgen Inc. |
Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
|
|
GB9320660D0
(en)
|
1993-10-07 |
1993-11-24 |
British Bio Technology |
Inhibition of cytokine production
|
|
US6037472A
(en)
|
1993-11-04 |
2000-03-14 |
Syntex (U.S.A.) Inc. |
Matrix metalloprotease inhibitors
|
|
US5780014A
(en)
*
|
1995-04-14 |
1998-07-14 |
Inhale Therapeutic Systems |
Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
|
|
DE19541873A1
(de)
|
1995-11-09 |
1997-05-15 |
Rhodia Ag Rhone Poulenc |
Filterzigarette
|
|
AU2645497A
(en)
|
1996-05-06 |
1997-11-26 |
Zeneca Limited |
Thio derivatives of hydroxamic acids
|
|
USRE37053E1
(en)
*
|
1996-05-24 |
2001-02-13 |
Massachusetts Institute Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
|
US5780440A
(en)
*
|
1996-06-17 |
1998-07-14 |
Protease Sciences Inc. |
Treatment of pulmonary disease with protease inhibitors
|
|
GB9715962D0
(en)
|
1996-08-23 |
1997-10-01 |
Zeneca Ltd |
Sulfonamides
|
|
US6610683B2
(en)
*
|
1996-09-12 |
2003-08-26 |
Idun Pharmaceuticals, Inc. |
Treatment of infectious disease using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
|
|
ID22212A
(id)
|
1996-10-02 |
1999-09-16 |
Novartis Ag |
Turunan-turunan asam hidroksamat
|
|
JP2001517225A
(ja)
|
1997-03-28 |
2001-10-02 |
ゼネカ リミテッド |
Ｎ−（３−ヒドロキシ−スクシニル）−アミノ酸誘導体調製のためのプロセス
|
|
FR2762315B1
(fr)
|
1997-04-22 |
1999-05-28 |
Logeais Labor Jacques |
Derives d'amino-acides inhibiteurs des metalloproteases de la matrice extracellulaire et de la liberation du tnf alpha
|
|
US6124257A
(en)
*
|
1997-08-28 |
2000-09-26 |
Lezdey; John |
Method of treatment
|
|
US20010006939A1
(en)
|
1997-10-03 |
2001-07-05 |
Ralph W. Niven |
Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions
|
|
US5972986A
(en)
*
|
1997-10-14 |
1999-10-26 |
G.D. Searle & Co. |
Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
|
|
WO1999032150A1
(en)
*
|
1997-12-23 |
1999-07-01 |
Warner-Lambert Company |
Ace inhibitor-mmp inhibitor combinations
|
|
GB9804504D0
(en)
|
1998-03-03 |
1998-04-29 |
Leo Pharm Prod Ltd |
Matrix metalloproteinase inhibitors
|
|
US5996589A
(en)
|
1998-03-03 |
1999-12-07 |
Brown & Williamson Tobacco Corporation |
Aerosol-delivery smoking article
|
|
EP1137633A2
(en)
|
1998-12-09 |
2001-10-04 |
American Home Products Corporation |
Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
|
|
WO2000051623A2
(en)
*
|
1999-03-05 |
2000-09-08 |
The Trustees Of University Technology Corporation |
Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide-induced clinical conditions
|
|
AU778042B2
(en)
|
1999-10-19 |
2004-11-11 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
HRP20020349A2
(en)
|
1999-10-19 |
2004-02-29 |
Merck & Co Inc |
Tyrosine kinase inhibitors
|
|
EE200200426A
(et)
*
|
2000-01-31 |
2003-12-15 |
Pfizer Products Inc. |
PDE4 isosüümide inhibiitoritena kasulikud pürimidiinkarboksamiidid
|
|
GB0004531D0
(en)
*
|
2000-02-25 |
2000-04-19 |
Richards Andrew J M |
The treatment of respiratory diseases
|
|
GB0008660D0
(en)
*
|
2000-04-07 |
2000-05-31 |
Arakis Ltd |
The treatment of respiratory diseases
|
|
US6637430B1
(en)
|
2000-06-16 |
2003-10-28 |
Ponwell Enterprises Limited |
Respiratory delivery system with power/medicament recharge assembly
|
|
US20020099013A1
(en)
*
|
2000-11-14 |
2002-07-25 |
Thomas Piccariello |
Active agent delivery systems and methods for protecting and administering active agents
|
|
EP1366175B1
(en)
|
2000-12-18 |
2008-01-23 |
Arriva Pharmaceuticals, Inc. |
Multifunctional protease inhibitors and their use in treatment of disease
|
|
US7247704B2
(en)
*
|
2000-12-18 |
2007-07-24 |
Arriva Pharmaceuticals, Inc. |
Multifunctional protease inhibitors and their use in treatment of disease
|
|
EP1351678A2
(en)
|
2001-01-02 |
2003-10-15 |
Elizabeth Shanahan-Prendergast |
Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens
|
|
PA8539301A1
(es)
|
2001-02-14 |
2002-09-30 |
Warner Lambert Co |
Inhibidores de la metaloproteinasa de la matriz
|
|
US6544497B2
(en)
*
|
2001-02-15 |
2003-04-08 |
Aeropharm Technology Incorporated |
Modulated release particles for aerosol delivery
|
|
US6789546B2
(en)
|
2001-06-26 |
2004-09-14 |
Technion Research & Development Foundation Ltd. |
Filters for preventing or reducing tobacco smoke-associated injury in the aerodigestive tract of a subject
|
|
WO2003035610A1
(en)
*
|
2001-10-26 |
2003-05-01 |
Shionogi & Co., Ltd. |
Sulfonamide derivative having mmp inhibitory activity
|
|
US20030211548A1
(en)
*
|
2002-01-29 |
2003-11-13 |
Oncolmmunin, Inc. |
Visualization and quantitiation of cellular cytotoxicity using cell-permeable fluorogenic protease substrates and caspase activity indicator markers
|
|
EP1513502B1
(en)
|
2002-02-18 |
2015-12-30 |
Ockham Biotech Limited |
Combination therapy for respiratory disorders
|
|
WO2003075959A1
(en)
|
2002-03-08 |
2003-09-18 |
Novartis Ag |
Matrix metalloproteinase inhibitors in combination with hypothermia and/or radiotherapy for the treatment of cancer
|
|
AU2003235121A1
(en)
*
|
2002-04-26 |
2003-11-10 |
Takeda Pharmaceutical Company Limited |
Novel thiol derivative, process for producing the same and use thereof
|
|
US7165362B2
(en)
*
|
2002-07-15 |
2007-01-23 |
Apple Computer, Inc. |
Glass support member
|
|
US6810883B2
(en)
|
2002-11-08 |
2004-11-02 |
Philip Morris Usa Inc. |
Electrically heated cigarette smoking system with internal manifolding for puff detection
|
|
AU2004240629B2
(en)
|
2003-05-16 |
2010-02-25 |
Arriva Pharmaceuticals, Inc. |
Treatment of respiratory disease by inhalation of synthetic matrix metalloprotease inhibitors
|
|
WO2005003150A2
(en)
|
2003-07-02 |
2005-01-13 |
Emory University |
Compositions and methods for use of a protease inhibitor and adenosine for preventing organ ischemia and reperfusion injury
|
|
JP2007511539A
(ja)
*
|
2003-11-14 |
2007-05-10 |
バクスター・インターナショナル・インコーポレイテッド |
α１−抗トリプシン組成物およびこのような組成物を用いた処置方法
|
|
CA2559062A1
(en)
*
|
2004-03-09 |
2005-09-22 |
Arriva Pharmaceuticals, Inc. |
Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor
|